Biotechnology Assets Company Description

Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally.

It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administered as DNA vaccines; and CLICK’N CUT, a tool to obtain tag-less proteins in a one-step process based on intein affinity, as well as Zebrafish assays.

The company is based in Cádiz, Spain.

Biotechnology Assets, S.A.

Country	Spain
Founded	1954
Industry	Biotechnology
Sector	Healthcare
Employees	34
CEO	Jaime Feced Rubio

Contact Details

Address: Av. del Desarrollo Tecnológico, 11 Cádiz, 11591 Spain
Phone	34 856 06 06 03
Website	biatgroup.com

Stock Details

Ticker Symbol	BST
Exchange	Madrid Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	ES0184980003
SIC Code	2834

Key Executives

Name	Position
Dr. Manuel Lopez Nieto	Chief Technical Officer